EUVIMEDEUVIMED entdecken
Crossref

Network pharmacology combined with metabolomics to reveal the anti-fibrotic mechanism of Polygoni Orientalis Fructus in CCl4-induced hepatic fibrosis rats

Lizhou Ma, Yu Chen, Rong Yue, Ziyu Li, Yibo Wang, Yanggang Bian, Miao Wang

Journal of Proteomics · 2024

DOI: 10.1016/j.jprot.2024.105227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteomics, 2024. Verfasst von Lizhou Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning 110016, China. Hauptthemen laut MEDLINE: Carbon Tetrachloride, Liver Cirrhosis, Network Pharmacology, Metabolomics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Scientific Research Fund of Liaoning Provincial Education Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polygoni Orientalis Fructus (POF), a dried ripe fruit of Polygonum orientale L., is commonly used in China for liver disease treatment. However, its therapeutic mechanism remains unclear. The aim of this study was to elucidate the effects of POF on the regulation of endogenous metabolites and identify its key therapeutic targets in hepatic fibrosis (HF) rats by integrating network pharmacology and metabolomics approaches. First, serum liver indices and histopathological analyses were used to evaluate the therapeutic effects of POF on carbon tetrachloride (CCl4)-induced HF. Subsequently, differential metabolites and potential therapeutic targets of POF were screened using plasma metabolomics and network pharmacology, respectively. The key targets of POF were identified by overlapping differential metabolite-associated targets with the potential targets and validated by molecular docking and ELISA experiments. The results showed that POF effectively alleviated HF in rats. A total of 51 metabolites related to HF were screened, and 24 were associated with POF. 232 potential therapeutic targets were identified by network pharmacology analysis. Finally, six key targets were identified through a combined analysis. Furthermore, molecular docking and ELISA validation revealed that AGXT, PAH, and NOS3 are targets of POF action, while CBS, ALDH2, and ARG1 were identified as potential targets. SIGNIFICANCE: POF is now commonly used in the treatment of liver disease, but its mechanism of action remains unclear. Current studies on metabolomics of liver disease primarily focuse on the interpretation of differential metabolites and related metabolic pathways. This research delves into the intricate details of metabolomics findings via network pharmacology to uncover the targets and pathways of drug action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon TetrachlorideLiver CirrhosisNetwork PharmacologyMetabolomicsAnimalsRatsMaleMolecular Docking SimulationPolygonumDrugs, Chinese HerbalRats, Sprague-DawleyFruit

Stichwörter der Autor:innen

Hepatic fibrosisMetabolomicsNetwork pharmacologyPolygoni Orientalis Fructus

Substanzen

Carbon TetrachlorideDrugs, Chinese Herbal

Autor:innen und Institutionen

  • School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning 110016, China.
  • School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning 110016, China.
  • School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning 110016, China. Electronic address: wangmiao@syphu.edu.cn.

Förderung

  • Scientific Research Fund of Liaoning Provincial Education Department

Zitieren

APA

Ma, L., Chen, Y., Yue, R., Li, Z., Wang, Y., Bian, Y., & Wang, M. (2024). Network pharmacology combined with metabolomics to reveal the anti-fibrotic mechanism of Polygoni Orientalis Fructus in CCl4-induced hepatic fibrosis rats. Journal of Proteomics. https://doi.org/10.1016/j.jprot.2024.105227

Vancouver

Ma L, Chen Y, Yue R, Li Z, Wang Y, Bian Y, et al. Network pharmacology combined with metabolomics to reveal the anti-fibrotic mechanism of Polygoni Orientalis Fructus in CCl4-induced hepatic fibrosis rats. Journal of Proteomics. 2024. doi:10.1016/j.jprot.2024.105227

BibTeX
@article{Ma2024,
  author = {Ma, Lizhou and Chen, Yu and Yue, Rong and Li, Ziyu and Wang, Yibo and Bian, Yanggang and Wang, Miao},
  title = {Network pharmacology combined with metabolomics to reveal the anti-fibrotic mechanism of Polygoni Orientalis Fructus in CCl4-induced hepatic fibrosis rats},
  journal = {Journal of Proteomics},
  year = {2024},
  doi = {10.1016/j.jprot.2024.105227}
}
Kostenlos starten →